Evidence map›Paper›PMID 31342731›Full record

ReviewChronic obstructive pulmonary diseases (Miami, Fla.)2019

Physiologic Insights from the COPD Genetic Epidemiology Study.

William W Stringer, Janos Porszasz, Surya P Bhatt, Meredith C McCormack, Barry J Make, Richard Casaburi

Abstract readReview
In one paragraph

Review in Chronic obstructive pulmonary diseases (Miami, Fla.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Re-Defining High Risk COPD with Parameter Response Mapping Based on Machine Learning Models.International journal of chronic obstructive pulmonary disease · 2022
    Article
  6. Is this asthma, COPD, or both?Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2021
    Article
  7. Early diagnosis of COPD: myth or a true perspective.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

William W StringerLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Janos PorszaszLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Surya P BhattDivision of Pulmonary, Allergy, and Critical Care Medicine and Lung Health Center, University of Alabama, Birmingham.
Meredith C McCormackDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Barry J MakeDepartment of Medicine, National Jewish Health, Denver, Colorado.
Richard CasaburiLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
COPD Foundation Industry Advisory BoardNHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

COPD Genetic Epidemiology Study (COPDGene

Indexed as

asthma-COPD overlapchronic obstructive pulmonary diseasecopdCOPDGeneCOPD Genetic EpidemiologyPreserved Ratio Impaired SpirometryPRISm

Identifiers

PMID31342731
PMCPMC6872216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.